Iberogast (Milk Thistle Fruit Extract, Bitter Candytuft Fresh Plant Extract, Matricaria Liquid Extract, Menthae)

The blend of milk thistle, bitter candytuft, chamomile, peppermint and other plant extracts modulates gut motility, reduces visceral sensitivity, and influences prostaglandin and transient receptor potential pathways. This multifactorial action helps normalise stomach emptying and soothe the gastrointestinal tract.

The dosage of Iberogast is determined by the prescribing healthcare professional based on the individual’s condition, age and response. Patients should follow the prescriber’s instructions and the product label without altering the recommended amount.

Safety data for Iberogast in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using the product.

To order Iberogast, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with conventional prokinetic or acid‑suppressive drugs, Iberogast offers a multi‑herbal approach that targets motility, sensitivity and inflammation simultaneously. It is an over‑the‑counter option, whereas many alternatives require prescription and may have a narrower mechanism of action.

Iberogast should be stored at ambient temperature, preferably below 25 °C. Keep the bottle tightly closed, protect it from moisture and direct sunlight, and retain it in the original packaging to maintain product stability.

Iberogast is taken orally as a liquid. The usual method is to measure the recommended dose with the supplied dropper or measuring device and swallow it directly or mix it with a small amount of water, as directed by a healthcare professional.

Serious risks, though rare, include allergic reactions such as rash, urticaria, facial swelling, and in extreme cases anaphylaxis. Hepatic enzyme elevations have also been reported, so liver function monitoring may be advisable for long‑term users.

Individuals with known hypersensitivity to any of the herbal components, those with severe liver disease without medical supervision, and patients taking anticoagulants or strong CYP‑inducing drugs should avoid Iberogast unless advised otherwise by a qualified healthcare professional.